This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Davatchi, F., Shahram, F., Akbarian, M., et al., 1997, Behçet’s disease — Analysis of 3443 cases. APLAR J. Rheumatol. 1: 2–5.
Davatchi, F., 1998, Behçet’s disease. In Textbook of Clinical Rheumatology (H.S. Howe, and P.H. Feng, eds.), National Arthritis Foundation, Singapore, pp. 298–315.
Davatchi, F., Shahram, F., Chams, H., et al., 2001, Long-term outcome of vision in Behçet’s disease. Arthritis Rheum. 44: S1309.
Davatchi, F., Shahram, F., Chams, H., et al., 2003, The influence of the delay of aggressive treatment on the vision and its outcome in Behçet’s disease. In Adamantiades-Behçet’s disease (Ch.C. Zouboulis, ed.), Kluwer/Plenum, London, pp. 493–494.
Davatchi, F., Shahram, F., Chams, H., et al., 1991, Pulse cyclophosphamide in ophthalmological manifestations of Behçet’s disease. In Behçet’ s Disease. Basic and Clinical Aspects (J.D. O’Duffy, and E. Kokmen, eds.), Marcel Decker, New York, pp. 555–561.
Davatchi, F., Shahram, F., Chams, H., et al., 1998, Pulse cyclophosphamide for ocular manifestations of Behçet’s disease. Cohort study on 283 patients. Rev. Rheum. (Engl. Ed.) 65: 692.
Shahram, F., Davatchi, F., Chams, H., et al., 1993, Low dose pulse cyclophosphamide LDP) in ophthalmologic lesions of Behçet’s disease. In Behçet’s Disease (B. Wechsler, and P. Godeau, eds.), Excerpta Medica, Amsterdam, pp. 683–686.
Shahram, F., Davatchi, F., Chams, H., et al., 1992, Pulse cyclophosphamide versus pulse methotrexate in ophthalmological manifestations of Behçet’s disease. In APLAR Rheumatology 1992 (A. Nasution, J. Darmawan, and H. Isbagio, eds.), Churchill Livingstone, Tokyo, pp. 119–122.
Shahram, F., Davatchi, F., Chams, H., et al., 1990, Methotrexate in ocular Behçet disease. Preliminary report. In First APLAR Symposium on the Therapy of Rheumatic Diseases, Seoul, Korea. Abstract FP-23.
Davatchi, F., Shahram, F., Chams, H., et al., 1998, Methotrexate for ocular lesions of Behçet’s disease. Cohort study on 262 patients. Arthritis Rheum. 41: S356.
Shahram, F., Davatchi, F., Chams, H., et al., 1993, Comparing 3 methods of cytotoxic therapy in ophthalmologic lesions of Behçet’s disease. In Behçet’s Disease (B. Wechsler, and P. Godeau, eds.), Excerpta Medica, Amsterdam, pp. 635–640.
Shahram, F., Davatchi, F., Chams, H., et al., 1997, Cyclosporin in sever ocular lesions of Behçet’s disease. In Behçet’s Disease (M. Hamza, ed.), Pub Adoua, Tunis, pp. 421–423.
Davatchi, F., Shahram, F., Chams, H., 2000, Azathioprine for the treatment of ophthalmological lesions of Behçet’s disease. In Behcet’s Disease (D. Bang, E.-S. Lee, S. Lee, eds.), Design Mecca Publishing, Seoul, pp. 898–900.
Shahram, F., Chams, H., Davatchi, F., et al., 2000, Combination therapy with low dose pulse cyclophosphamide and methotrexate in ocular lesions of Behçet’s disease. In Behcet’s Disease (D. Bang, E.-S. Lee, S. Lee, eds.), Design Mecca Publishing, Seoul, pp. 926.
Davatchi, F., Shahram, F., Gharibdoost F., et al., 1996, Outcome analysis of ocular lesions in Behçet’s disease with 6 different therapeutic methods. Arthritis Rheum. 39: S217.
Davatchi, F., 1997, Neuro-ophthalmic Behçet’s. In APLAR 3rd Symposium on the Therapy of Rheumatic Diseases (T.P. Torralba, C.M. Amante, and S.T.G. Victorio-Navarra, eds.), Excerpta Medica, Hong Kong, pp. 16–17.
Davatchi, F., 2000, Treatment of ocular manifestations of Behçet’s disease. In Proceedings of the 9th Asia Pacific League of Associations for Rheumatology Congress, Beijing, pp. 174–176.
Adler, Y.D., Krause, L., Foerster, M.H., et al., 2000, Treatment of ocular Adamantiades-Behçet’s disease with interferon-alpha. In Behcet’s Disease (D. Bang, E.-S. Lee, S. Lee, eds.), Design Mecca Publishing, Seoul, pp. 446–447.
Wechsler, B., Huong-Boutin, L.T.D., Amoura, Z., et al., 2000, Efficacy of alpha interferon in severe and refractory uveitis of Behçet’s disease. In Behcet’s Disease (D. Bang, E.-S. Lee, S. Lee, eds.), Design Mecca Publishing, Seoul, pp. 483–488.
Kötter, I., Stübiger, N., Eckstein, A.K., et al., 2000, Recmbinant human interferon-α2A (IFNα2A) in the treatment of ocular Behçet’s disease (BD). In Behcet’s Disease (D. Bang, E.-S. Lee, S. Lee, eds.), Design Mecca Publishing, Seoul, pp. 491–493.
Nussenblatt, R.B., Palestine, A.G., and Clan, C.C., 1985, Effectiveness of cyclosporin therapy for Behçet’s disease. Arthritis Rheum. 28: 671–679.
Whitcup, S.M., Salvo, E.C. Jr., and Nussenblatt. R.B., 1994, Combined cyclosporine and corticosteroid therapy for sight-threatening uveitis in Behçet’s disease. Am. J. Ophthalmol. 118: 39–45.
Davatchi, F., Shahram, F., Gharibdoost, F., et al., 1997, Outcome of patients with ocular lesions of Behçet’s disease non responding to classical treatments. Arthritis Rheum. 40: S66.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Kluwer Academic Publishers
About this chapter
Cite this chapter
Davatchi, F. (2004). Treatment of Ocular Manifestations of Behçet’s Disease. In: Zouboulis, C.C. (eds) Adamantiades-Behçet’s Disease. Advances in Experimental Medicine and Biology, vol 528. Springer, Boston, MA. https://doi.org/10.1007/0-306-48382-3_99
Download citation
DOI: https://doi.org/10.1007/0-306-48382-3_99
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-306-47757-7
Online ISBN: 978-0-306-48382-0
eBook Packages: Springer Book Archive